A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
Status:
Recruiting
Trial end date:
2022-12-11
Target enrollment:
Participant gender:
Summary
This is an open label, multicentre, Phase Ib/II Clinical Study of AK109 and AK104 With or
Without Chemotherapy in Second-line Treatment of Advanced Gastric Adenocarcinoma or
Gastroesophageal Junction Adenocarcinoma .